{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:35Z","timestamp":1789748075087,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R01AR078343"],"award-info":[{"award-number":["R01AR078343"]}]},{"name":"NIH","award":["R01AI155907"],"award-info":[{"award-number":["R01AI155907"]}]},{"name":"NIH\/NSF","award":["1R01GM144966-01"],"award-info":[{"award-number":["1R01GM144966-01"]}]},{"name":"NSF","award":["2145877"],"award-info":[{"award-number":["2145877"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13346-023-01333-8","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T09:03:51Z","timestamp":1679907831000},"page":"1925-1935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaccines prevent reinduction of rheumatoid arthritis symptoms in collagen-induced arthritis mouse model"],"prefix":"10.1007","volume":"13","author":[{"given":"Abhirami","family":"Thumsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivatsan J.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn L.","family":"Mangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirami P.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-2764","authenticated-orcid":false,"given":"Abhinav P.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"issue":"9","key":"1333_CR1","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/RHEUMATOLOGY\/KEZ655","volume":"59","author":"JF Chen","year":"2020","unstructured":"Chen JF, et al. The impact of long-term biologics\/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis. Rheumatology (Oxford). 2020;59(9):2471. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEZ655.","journal-title":"Rheumatology (Oxford)"},{"key":"1333_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/CEI.13256","volume":"196","author":"P Wehr","year":"2019","unstructured":"Wehr P, Purvis H, Law SC. Thomas R Dendritic cells, T cells and their interaction in rheumatoid arthritis. Clin Exp Immunol. 2019;196:1. https:\/\/doi.org\/10.1111\/CEI.13256.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1333_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrrheum.2009.185","volume":"5","author":"S Khan","year":"2009","unstructured":"Khan S, Greenberg JD, Bhardwaj N. Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):566\u201371. https:\/\/doi.org\/10.1038\/nrrheum.2009.185.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1333_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.BJ.2020.06.010","volume":"44","author":"MI Edilova","year":"2021","unstructured":"Edilova MI, Akram A, Abdul-Sater AA. Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed J. 2021;44(2):172. https:\/\/doi.org\/10.1016\/J.BJ.2020.06.010.","journal-title":"Biomed J"},{"issue":"10","key":"1333_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","volume":"16","author":"E Neumann","year":"2010","unstructured":"Neumann E, Lef\u00e8vre S, Zimmermann B, Gay S, M\u00fcller-Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med. 2010;16(10):458\u201368. https:\/\/doi.org\/10.1016\/j.molmed.2010.07.004.","journal-title":"Trends Mol Med"},{"issue":"13","key":"1333_CR6","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1182\/BLOOD-2002-03-0671","volume":"100","author":"F Ponchel","year":"2002","unstructured":"Ponchel F, et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood. 2002;100(13):4550\u20136. https:\/\/doi.org\/10.1182\/BLOOD-2002-03-0671.","journal-title":"Blood"},{"key":"1333_CR7","doi-asserted-by":"publisher","unstructured":"Ponchel F, et al. T-cell subset abnormalities predict progression along the inflammatory arthritis disease continuum: implications for management. Sci Reports 2020;10(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-020-60314-w.","DOI":"10.1038\/s41598-020-60314-w"},{"key":"1333_CR8","doi-asserted-by":"publisher","unstructured":"Chang MH, et al. Arthritis flares mediated by tissue-resident memory T cells in the joint. Cell Rep. 2021;(37)4:109902. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109902.","DOI":"10.1016\/J.CELREP.2021.109902"},{"key":"1333_CR9","doi-asserted-by":"publisher","unstructured":"Lin YJ, Anzaghe M, Sch\u00fclke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4). https:\/\/doi.org\/10.3390\/CELLS9040880.","DOI":"10.3390\/CELLS9040880"},{"issue":"Suppl 1","key":"1333_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/AR2412","volume":"10","author":"AP Cope","year":"2008","unstructured":"Cope AP. T cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10(Suppl 1):S1. https:\/\/doi.org\/10.1186\/AR2412.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1333_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ART.1780390518","volume":"39","author":"CL Kohem","year":"1996","unstructured":"Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27 \u2013 memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39(5):844\u201354. https:\/\/doi.org\/10.1002\/ART.1780390518.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1333_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00357-9","volume":"11","author":"K Nagatani","year":"2021","unstructured":"Nagatani K, Sakashita E, Endo H, Minota S. A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis. Sci Reports. 2021;11(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-00357-9.","journal-title":"Sci Reports"},{"issue":"4","key":"1333_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncprheum0142","volume":"2","author":"CM Weyand","year":"2006","unstructured":"Weyand CM, Goronzy JJ. T-cell-targeted therapies in rheumatoid arthritis. Nat Clin Pract Rheumatol. 2006;2(4):201\u201310. https:\/\/doi.org\/10.1038\/ncprheum0142.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"1333_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3892\/BR.2012.42","volume":"1","author":"X Ma","year":"2013","unstructured":"Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Reports. 2013;1(2):177. https:\/\/doi.org\/10.3892\/BR.2012.42.","journal-title":"Biomed Reports"},{"issue":"7","key":"1333_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/J.BIOPHA.2010.01.007","volume":"64","author":"S Xinqiang","year":"2010","unstructured":"Xinqiang S, et al. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines. Biomed Pharmacother. 2010;64(7):463\u201371. https:\/\/doi.org\/10.1016\/J.BIOPHA.2010.01.007.","journal-title":"Biomed Pharmacother"},{"key":"1333_CR16","doi-asserted-by":"publisher","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME Methotrexate for treating rheumatoid arthritis Cochrane Database Syst Rev 2014;2014(6). https:\/\/doi.org\/10.1002\/14651858.CD000957.PUB2.","DOI":"10.1002\/14651858.CD000957.PUB2"},{"issue":"10","key":"1333_CR17","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/BCP.14057","volume":"85","author":"CJ Lucas","year":"2019","unstructured":"Lucas CJ, Dimmitt SB, Martin JH. Optimising low-dose methotrexate for rheumatoid arthritis\u2014a review. Br J Clin Pharmacol. 2019;85(10):2228\u201334. https:\/\/doi.org\/10.1111\/BCP.14057.","journal-title":"Br J Clin Pharmacol"},{"key":"1333_CR18","unstructured":"Albrecht K, M ler-Ladner U. Side effects and management of side effects of methotrexate in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(5 SUPPL. 61): S95\u2013S101. [Online]. Available: https:\/\/www.clinexprheumatol.org\/article.asp?a=4095%0Ahttp:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=emed9&NEWS=N&AN=2010707610."},{"issue":"4","key":"1333_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/15360288.2014.959238","volume":"28","author":"CG Shinde","year":"2014","unstructured":"Shinde CG, Venkatesh MP, Kumar TMP, Shivakumar HG. Methotrexate: a gold standard for treatment of rheumatoid arthritis. J Pain Palliat Care Pharmacother. 2014;28(4):351\u20138. https:\/\/doi.org\/10.3109\/15360288.2014.959238.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"1333_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1715163518756679","volume":"151","author":"C Zenuk","year":"2018","unstructured":"Zenuk C. Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy. Can Pharm J CPJ. 2018;151(2):94. https:\/\/doi.org\/10.1177\/1715163518756679.","journal-title":"Can Pharm J CPJ"},{"issue":"August","key":"1333_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.biomaterials.2022.121973","volume":"293","author":"S Inamdar","year":"2022","unstructured":"Inamdar S, et al. Biomaterial mediated simultaneous delivery of spermine and alpha ketoglutarate modulate metabolism and innate immune cell phenotype in sepsis mouse models. Biomaterials. 2022;293(August):2023. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121973.","journal-title":"Biomaterials"},{"key":"1333_CR22","doi-asserted-by":"crossref","unstructured":"Mangal JL, et al. Inhibition of glycolysis in the presence of antigen generates suppressive antigen-specific responses and restrains rheumatoid arthritis in mice, 2021;277. Elsevier Ltd, 2021.","DOI":"10.1016\/j.biomaterials.2021.121079"},{"key":"1333_CR23","doi-asserted-by":"publisher","unstructured":"Mangal JL, Basu N, Wu HJJ, Acharya AP. Immunometabolism: an emerging target for immunotherapies to treat rheumatoid arthritis. Immunometabolism. 2021.\u00a0https:\/\/doi.org\/10.20900\/immunometab20210032.","DOI":"10.20900\/immunometab20210032"},{"key":"1333_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2016.03.013","volume":"44","author":"F Teng","year":"2016","unstructured":"Teng F, et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer\u2019s patch T follicular helper cells. Immunity. 2016;44:875\u201388. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.013.","journal-title":"Immunity"},{"issue":"2","key":"1333_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3181\/00379727-177-41955","volume":"177","author":"JE Price","year":"1984","unstructured":"Price JE, Barth RF, Johnson CW, Staubus AE. Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routes. Proc Soc Exp Biol Med. 1984;177(2):347\u201353. https:\/\/doi.org\/10.3181\/00379727-177-41955.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"1333_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/0300985815588612","volume":"52","author":"P Caplazi","year":"2015","unstructured":"Caplazi P, et al. Mouse models of rheumatoid arthritis. Vet Pathol. 2015;52(5):819\u201326. https:\/\/doi.org\/10.1177\/0300985815588612.","journal-title":"Vet Pathol"},{"issue":"1","key":"1333_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S00281-003-0125-3","volume":"25","author":"P Li","year":"2003","unstructured":"Li P, Schwarz EM. The TNF-\u03b1 transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol. 2003;25(1):19\u201333. https:\/\/doi.org\/10.1007\/S00281-003-0125-3.","journal-title":"Springer Semin Immunopathol"},{"issue":"1","key":"1333_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2003.11.004","volume":"10","author":"HJ Ditzel","year":"2004","unstructured":"Ditzel HJ. The K\/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med. 2004;10(1):40\u20135. https:\/\/doi.org\/10.1016\/j.molmed.2003.11.004.","journal-title":"Trends Mol Med"},{"key":"1333_CR29","doi-asserted-by":"publisher","unstructured":"Nandakumar KS, Holmdahl R.\u00a0Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.\u00a0Arthritis Res Ther. 2006;8(6)223.\u00a0https:\/\/doi.org\/10.1186\/AR2089.","DOI":"10.1186\/AR2089"},{"key":"1333_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8802-0_1","volume":"1868","author":"M Miyoshi","year":"2018","unstructured":"Miyoshi M, Liu S. Collagen-induced arthritis models. Methods Mol Biol. 2018;1868:3\u20137. https:\/\/doi.org\/10.1007\/978-1-4939-8802-0_1.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"1333_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/art.40482","volume":"70","author":"C Hagert","year":"2018","unstructured":"Hagert C, et al. Chronic active arthritis driven by macrophages without involvement of T cells: a novel experimental model of rheumatoid arthritis. Arthritis Rheumatol. 2018;70(8):1343\u201353. https:\/\/doi.org\/10.1002\/art.40482.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1333_CR32","doi-asserted-by":"publisher","first-page":"R1148","DOI":"10.1186\/AR1800","volume":"7","author":"E Bajtner","year":"2005","unstructured":"Bajtner E, Nandakumar KS, Engstr\u00f6m A, Holmdahl R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther. 2005;7(5):R1148. https:\/\/doi.org\/10.1186\/AR1800.","journal-title":"Arthritis Res Ther"},{"key":"1333_CR33","doi-asserted-by":"publisher","unstructured":"Butz DE, Li G, Huebner SM, Cook ME.\u00a0A mechanistic approach to understanding conjugated linoleic acid\u2019s role in inflammation using murine models of rheumatoid arthritis. Am J Physiol Regul Integr Comp Physiol.\u00a02007;293(2).\u00a0https:\/\/doi.org\/10.1152\/AJPREGU.00005.2007\/ASSET\/IMAGES\/LARGE\/ZH60090759320005.JPEG.","DOI":"10.1152\/AJPREGU.00005.2007\/ASSET\/IMAGES\/LARGE\/ZH60090759320005.JPEG"},{"key":"1333_CR34","doi-asserted-by":"publisher","unstructured":"Tuncel\u00a0J,\u00a0et al. Self-reactive T cells induce and perpetuate chronic relapsing arthritis. Arthritis Res Ther.\u00a02020;22(1). https:\/\/doi.org\/10.1186\/s13075-020-2104-7.","DOI":"10.1186\/s13075-020-2104-7"},{"issue":"1","key":"1333_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/laban0108-26","volume":"37","author":"CD Steel","year":"2008","unstructured":"Steel CD, Stephens AL, Hahto SM, Singletary SJ, Ciavarra RP. Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim (NY). 2008;37(1):26\u201332. https:\/\/doi.org\/10.1038\/laban0108-26.","journal-title":"Lab Anim (NY)"},{"issue":"5","key":"1333_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/LABAN0511-155","volume":"40","author":"T Yardeni","year":"2011","unstructured":"Yardeni T, Eckhaus M, Morris HD, Huizing M, Hoogstraten-Miller S. Retro-orbital injections in mice. Lab Anim (NY). 2011;40(5):155. https:\/\/doi.org\/10.1038\/LABAN0511-155.","journal-title":"Lab Anim (NY)"},{"issue":"1","key":"1333_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5045\/br.2016.51.1.31","volume":"51","author":"YK Kang","year":"2016","unstructured":"Kang YK, et al. Humanizing NOD\/SCID\/IL-2R\u03b3null (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34+ cells. Blood Res. 2016;51(1):31\u20136. https:\/\/doi.org\/10.5045\/br.2016.51.1.31.","journal-title":"Blood Res"},{"issue":"10086","key":"1333_CR38","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(17)31491-5.","journal-title":"Lancet"},{"key":"1333_CR39","doi-asserted-by":"publisher","unstructured":"Zijlstra TR, Moens HB, Bukhari MA.\u00a0The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA. Ann Rheum Dis. 2002;61(1):20.\u00a0https:\/\/doi.org\/10.1136\/ARD.61.1.20.","DOI":"10.1136\/ARD.61.1.20"},{"key":"1333_CR40","doi-asserted-by":"publisher","unstructured":"Trikha\u00a0R,\u00a0et al. Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection. PLoS One, 2021;16(8):e0250910.\u00a0https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0250910.","DOI":"10.1371\/JOURNAL.PONE.0250910"},{"key":"1333_CR41","doi-asserted-by":"publisher","unstructured":"van Delft\u00a0MAM, Huizinga TWJ. An overview of autoantibodies in rheumatoid arthritis. J. Autoimmun.\u00a02020;110:102392.\u00a0https:\/\/doi.org\/10.1016\/J.JAUT.2019.102392.","DOI":"10.1016\/J.JAUT.2019.102392"},{"key":"1333_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4236\/mri.2016.53004","volume":"5","author":"PI P\u00e9rez-Mart\u00ednez","year":"2016","unstructured":"P\u00e9rez-Mart\u00ednez PI, Hern\u00e1ndez VG, Rodr\u00edguez-Espinosa O, Arce-Paredes P, Rojas-Espinosa O. Differential anti-inflammatory effects of three purified omega unsaturated fatty acids on collagen-induced arthritis in mouse. Mod Res Inflamm. 2016;5:31\u201344. https:\/\/doi.org\/10.4236\/mri.2016.53004.","journal-title":"Mod Res Inflamm"},{"issue":"24","key":"1333_CR43","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1039\/d0tb00790k","volume":"8","author":"JL Mangal","year":"2020","unstructured":"Mangal JL, et al. Metabolite releasing polymers control dendritic cell function by modulating their energy metabolism. J Mater Chem B. 2020;8(24):5195\u2013203. https:\/\/doi.org\/10.1039\/d0tb00790k.","journal-title":"J Mater Chem B"},{"key":"1333_CR44","doi-asserted-by":"publisher","unstructured":"Bolon B,\u00a0et al. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol.\u00a02011;2011.\u00a0https:\/\/doi.org\/10.1155\/2011\/569068.","DOI":"10.1155\/2011\/569068"},{"issue":"2","key":"1333_CR45","first-page":"114","volume":"55","author":"DD Brand","year":"2005","unstructured":"Brand DD. Rodent models of rheumatoid arthritis the need for rodent models of arthritis. Comp Med. 2005;55(2):114\u201322.","journal-title":"Comp Med"},{"key":"1333_CR46","doi-asserted-by":"publisher","unstructured":"Zhang Z, Cao Y, Yuan Q, Zhang A, Zhang K, Wang Z.\u00a0Shexiang-Wulong pills attenuate rheumatoid arthritis by alleviating inflammation in a mouse model of collagen-induced arthritis. Evidence-based Complement Altern Med.\u00a02019;2019.\u00a0https:\/\/doi.org\/10.1155\/2019\/5308405.","DOI":"10.1155\/2019\/5308405"},{"issue":"3","key":"1333_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","volume":"9","author":"EH Choy","year":"2013","unstructured":"Choy EH, Kavanaugh AF, Jones SA. The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol. 2013;9(3):154\u201363. https:\/\/doi.org\/10.1038\/nrrheum.2013.8.","journal-title":"Nat Rev Rheumatol"},{"key":"1333_CR48","doi-asserted-by":"crossref","unstructured":"Rubbert-Roth A, Szab\u00f3 MZ, Kedves M, Nagy G, Atzeni F, Sarzi-Puttini P.\u00a0Failure of anti-TNF treatment in patients with rheumatoid arthritis: the pros and cons of the early use of alternative biological agents. Autoimmun Rev. 2019;18(12).","DOI":"10.1016\/j.autrev.2019.102398"},{"key":"1333_CR49","doi-asserted-by":"publisher","unstructured":"Atzeni F, Sarzi-Puttini P. The therapeutic journey of biologic agents: there will be an end?. Pharmacol Res.\u00a02019;147.\u00a0https:\/\/doi.org\/10.1016\/J.PHRS.2019.104340.","DOI":"10.1016\/J.PHRS.2019.104340"},{"key":"1333_CR50","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3389\/FIMMU.2020.591365\/BIBTEX","volume":"11","author":"F Zamri","year":"2020","unstructured":"Zamri F, de Vries TJ. Use of TNF inhibitors in rheumatoid arthritis and implications for the periodontal status: for the benefit of both? Front Immunol. 2020;11:2686. https:\/\/doi.org\/10.3389\/FIMMU.2020.591365\/BIBTEX.","journal-title":"Front Immunol"},{"issue":"20","key":"1333_CR51","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/ARCHINTE.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337\u201344. https:\/\/doi.org\/10.1001\/ARCHINTE.165.20.2337.","journal-title":"Arch Intern Med"},{"issue":"7","key":"1333_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.autrev.2019.05.007","volume":"18","author":"P Conigliaro","year":"2019","unstructured":"Conigliaro P, et al. Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev. 2019;18(7):706\u201313. https:\/\/doi.org\/10.1016\/j.autrev.2019.05.007.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1333_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ART.10092","volume":"46","author":"JR O\u2019Dell","year":"2002","unstructured":"O\u2019Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum. 2002;46(2):283\u20135. https:\/\/doi.org\/10.1002\/ART.10092.","journal-title":"Arthritis Rheum"},{"issue":"17","key":"1333_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2217\/pgs-2019-0121","volume":"20","author":"B Jekic","year":"2019","unstructured":"Jekic B, Maksimovic N, Damnjanovic T. Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis. Pharmacogenomics. 2019;20(17):1235\u201345. https:\/\/doi.org\/10.2217\/pgs-2019-0121.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"1333_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/J.JBSPIN.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019;86(3):301. https:\/\/doi.org\/10.1016\/J.JBSPIN.2018.07.004.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"1333_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16(3):145\u201354. https:\/\/doi.org\/10.1038\/s41584-020-0373-9.","journal-title":"Nat Rev Rheumatol"},{"key":"1333_CR57","doi-asserted-by":"publisher","unstructured":"Elia I. Integrating metabolic engineering and immunotherapy. Curr Opin Syst Biol.\u00a02021;28:100361.\u00a0https:\/\/doi.org\/10.1016\/J.COISB.2021.100361.","DOI":"10.1016\/J.COISB.2021.100361"},{"key":"1333_CR58","doi-asserted-by":"publisher","unstructured":"Qiu J, Wu B, Goodman SB, Berry GJ, Goronzy JJ, Weyand CM.\u00a0Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front Immunol. 2021;12.\u00a0https:\/\/doi.org\/10.3389\/FIMMU.2021.652771.","DOI":"10.3389\/FIMMU.2021.652771"},{"key":"1333_CR59","doi-asserted-by":"publisher","unstructured":"Garcia-Carbonell\u00a0R,\u00a0et al. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol (Hoboken, N.J.). 2016;68(7):1614\u201326.\u00a0https:\/\/doi.org\/10.1002\/ART.39608.","DOI":"10.1002\/ART.39608"},{"issue":"2","key":"1333_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0142-9612(03)00531-3","volume":"25","author":"MM Matzelle","year":"2004","unstructured":"Matzelle MM, Babensee JE. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. Biomaterials. 2004;25(2):295\u2013304.","journal-title":"Biomaterials"},{"issue":"9","key":"1333_CR61","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.actbio.2010.03.006","volume":"6","author":"SW Choe","year":"2010","unstructured":"Choe SW, Acharya AP, Keselowsky BG, Sorg BS. Intravital microscopy imaging of macrophage localization to immunogenic particles and co-localized tissue oxygen saturation. Acta Biomater. 2010;6(9):3491\u20138. https:\/\/doi.org\/10.1016\/j.actbio.2010.03.006.","journal-title":"Acta Biomater"},{"issue":"9","key":"1333_CR62","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1039\/C5TB01754H","volume":"4","author":"AP Acharya","year":"2016","unstructured":"Acharya AP, et al. A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation. J Mater Chem B Mater Biol Med. 2016;4(9):1672. https:\/\/doi.org\/10.1039\/C5TB01754H.","journal-title":"J Mater Chem B Mater Biol Med"},{"issue":"9","key":"1333_CR63","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/ARD.2007.080341","volume":"67","author":"H Yamada","year":"2008","unstructured":"Yamada H, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(9):1299\u2013304. https:\/\/doi.org\/10.1136\/ARD.2007.080341.","journal-title":"Ann Rheum Dis"},{"key":"1333_CR64","doi-asserted-by":"publisher","unstructured":"Li S,\u00a0et al. Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity. Sci Reports 2017 71. 2017;7(1)1\u201311.\u00a0https:\/\/doi.org\/10.1038\/s41598-017-05014-8.","DOI":"10.1038\/s41598-017-05014-8"},{"issue":"7","key":"1333_CR65","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","volume":"11","author":"P Luo","year":"2022","unstructured":"Luo P, et al. Immunomodulatory role of T helper cells in rheumatoid arthritis. Bone Jt res. 2022;11(7):426\u201338. https:\/\/doi.org\/10.1302\/2046-3758.117.BJR-2021-0594.R1.","journal-title":"Bone Jt res"},{"issue":"10","key":"1333_CR66","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/RHEUMATOLOGY\/KEN163","volume":"47","author":"JD Isaacs","year":"2008","unstructured":"Isaacs JD. Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future. Rheumatology. 2008;47(10):1461\u20138. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEN163.","journal-title":"Rheumatology"},{"key":"1333_CR67","doi-asserted-by":"publisher","unstructured":"Li J, Hsu HC, Mountz JD. The dynamic duo\u2013inflammatory M1 macrophages and Th17 cells in rheumatic diseases. J Orthop Rheumatol.\u00a02013;1(1)4.\u00a0https:\/\/doi.org\/10.13188\/2334-2846.1000002.","DOI":"10.13188\/2334-2846.1000002"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01333-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T10:28:46Z","timestamp":1699871326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01333-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01333-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"10 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors participated in preparing this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors provide consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Abhinav P. Acharya is affiliated with a start-up company, Immunometabolix, LLC and VaderBio, LLC. There are no other conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}